Notably, in the second osteosarcoma model that clears rapidly with CAR T cell therapy, mice treated with either tumor-clearing GD2- or B7H3-CAR T cells demonstrate no cognitive behavioral deficits in novel object recognition testing (Figure 1J), suggesting intact cognition following this relatively efficient CAR T cell-mediated tumor clearance. This evidence concerns the gene CD276 and osteosarcoma.